英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Cladribine
|
4291-63-8 |
克拉屈滨
|
克拉曲滨;克拉利宾;2-氯-2'-脱氧腺甙;2-氯-2'-脱氧腺苷;克拉曲滨 (克拉屈滨);克拉曲滨,克拉利宾;2-氯-2'-脱氧腺嘌呤核苷;2-氯-9-(3-脱氧-Β-D-呋喃阿拉伯糖基)腺嘌呤
|
C10H12ClN5O3 |
285.69 | |
Jervine
|
469-59-0 |
蒜黎芦碱
|
介藜芦碱;介芬胺;蒜藜芦碱;蒜黎芦碱;白藜芦碱;杰尔碱;杰尔文;介芬碱;芥芬鹼
|
C27H39NO3 |
425.6 | 207-417-9 |
Cerulenin
|
17397-89-6 |
浅蓝菌素
|
浅蓝菌素;2,3-环氧-4-氧-7,10-十二碳二烯酰胺;变蓝菌素;天蓝菌素
|
C12H17NO3 |
223.27 | 241-424-8 |
ilomastat
|
142880-36-2 |
伊洛马司他
|
GALARDIN;ILOMASTAT;GM 6001;GM-6001;CS-1405;伊洛马司他(GM6001);伊诺马司他;ILOMASTAT (GM6002,GALARDIN);ILOMASTAT 伊洛马司他
|
C20H28N4O4 |
388.47 | |
BMS-708163
|
1146699-66-2 |
Avagacestat (BMS-78163)
|
BMS708163;BMS 708163;(2R)-2-[N-[(4-氯苯基)磺酰基]-N-[2-氟-4-(1,2,4-恶二唑-3-基)苄基]氨基]-5,5,5-三氟戊酰胺;CS-262;BMS708163;BMS 708163;AVAGACESTAT
|
C20H17ClF4N4O4S |
520.884993 | |
Triacsin C
|
76896-80-5 |
三氮菌素 C
|
三氮菌素 C,来源于金霉素链霉菌;转染试剂-生物感染;三氮菌素 C
|
C11H17N3O |
207.27 | 616-408-2 |
PFI-3
|
1819363-80-8 |
PFI-3
|
(2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚烷-2-基]-2-丙烯-1-酮;PFI3;PFI 3;CS-1803
|
C19H19N3O2 |
321.37306 | |
Ailanthone
|
981-15-7 |
臭椿酮
|
臭椿酮;臭椿酮(臭椿苦酮);AILANTHONE 臭椿酮
|
C20H24O7 |
376.403 | |
(1S,3R)-RSL3
|
1219810-16-8 |
CS-249
|
RSL3 1S;3R-;1S;3R-RSL3;CS-2409;RSL 3;RSL-3
|
C23H21ClN2O5 |
440.88 | |
CC4
|
492-02-4 |
野决明定
|
野决明定
|
C24H30N4O2 |
406.5206 | |
Garcinol
|
78824-30-3 |
山竹子素
|
山竹子素
|
C38H50O6 |
602.8 | 200-258-5 |
(1R,4aS,10aR(-1,2,3,4,4a,9,10,10a-Octahydro-1-,4a-dimethyl-7-(1-methylethyl(-1-phenanthrenemethanamine hydrochloride
|
16496-99-4 |
LEELAMINE HYDROCHLORIDE
|
|
C20H32ClN |
321.92778 | |
trans-Ned 19
|
1354235-96-3 |
/
|
(1R,3S)-1-[3-[[4-(2-Fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid;trans-Ned 19;(1R,3S)-1-[3-[[4-(2-Fluorophenyl)-1-piperazinyl]Methyl]-4-Methoxyphenyl]-2,3,4,9-tetrahydro-1H-Pyrido[3,4-b]indole-3-carboxylic Acid
|
|||
N-[2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-N-2-PYRIDINYL-CYCLOHEXANECARBOXAMIDE MALEATE
|
634908-75-1 |
WAY-1635
|
WAY-100635 马来酸盐;N-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-N-2-吡啶基环己烷甲酰胺
|
C29H38N4O6 |
538.64 | |
QNZ46
|
1237744-13-6 |
QNZ46
|
CS-2059;QNZ-46;QNZ 46;QNZ46;CS-2438;QNZ 46;QNZ-46;4-[6-甲氧基-2-[(1E)-2-(3-硝基苯基)乙烯基]-4-氧代-3(4H)-喹唑啉基]苯甲酸
|
C24H17N3O6 |
443.40828 | |
talnetant
|
174636-32-9 |
TALNETANT
|
3-羟基-2-苯基-N-[(1S)-1-苯基丙基]-4-喹啉甲酰胺;(S)-3-羟基-2-苯基-N-(1-苯丙基)喹啉-5-甲酰胺
|
C25H22N2O2 |
382.45438 | |
Aurora A Inhibitor I
|
1158838-45-9 |
Aurora A Inhibitor I
|
N-(2-氯苯基)-4-[[2-[[4-[2-(4-乙基-1-哌嗪基)-2-氧代乙基]苯基]氨基]-5-氟-4-嘧啶基]氨基]苯甲酰胺
|
C31H31ClFN7O2 |
588.0749432 | |
Balicatib
|
354813-19-7 |
BALICATIB
|
BALICATIB;N-(1-(氰甲基氨甲酰)环己基)-4-(4-丙基哌嗪-1-基)苯甲酰胺
|
C23H33N5O2 |
411.55 | 200-256-5 |
SB 269970
|
261901-57-9 |
SB26997 HCl
|
(R)-3-((2-(2-(4-甲基哌啶-1-基)乙基)吡咯烷-1-基)磺酰基)苯酚盐酸盐
|
C18H28N2O3SHCl |
388.95246 | |
IEM 1754 Dihydrobromide
|
162831-31-4 |
IEM 1754 DIHYDROBROMIDE
|
|
C16H30 N2 . 2 Br H |
412.24668 |